| Crude Model |  | Model I |  | Model II |  |
---|---|---|---|---|---|---|
β (95%CI) | P value | β (95%CI) | P value | β (95%CI) | P value | |
Male | Â | Â | Â | Â | Â | Â |
HDL-C (mmol/L) | -7.03 (-9.18, -4.87) | < 0.001*** | -7.33 (-9.46, -5.19) | < 0.001*** | -8.77 (-11.65, -5.88) | < 0.001*** |
Q1 | Reference | Â | Reference | Â | Reference | Â |
Q2 | -2.92 (-4.57, -1.27) | 0.001** | -3.05 (-4.69, -1.42) | < 0.001*** | -2.08 (-3.66, -0.50) | 0.009** |
Q3 | -3.71 (-5.36, -2.07) | < 0.001*** | -3.92 (-5.55, -2.29) | < 0.001*** | -2.22 (-4.21, -0.23) | 0.029* |
Q4 | -5.51 (-7.14, -3.88) | < 0.001*** | -5.83 (-7.45, -4.22) | < 0.001*** | -2.32 (-5.32, 0.67) | 0.129 |
P for trend |  | < 0.001*** |  | < 0.001*** |  | 0.082 |
Female | Â | Â | Â | Â | Â | Â |
HDL-C (mmol/L) | 4.19 (1.01, 7.36) | 0.009** | -1.96 (-4.11, 0.18) | 0.073 | -4.77 (-8.63, -0.90) | 0.015* |
Q1 | Reference | Â | Reference | Â | Reference | Â |
Q2 | 0.89 (-1.93, 3.71) | 0.536 | -1.71 (-3.61, 0.19) | 0.078 | -0.36 (-2.63, 1.90) | 0.752 |
Q3 | 1.82 (-1.02, 4.66) | 0.209 | -1.79 (-3.71, 0.12) | 0.066 | 1.08 (-1.90, 4.08) | 0.476 |
Q4 | 4.28 (1.46, 7.09) | 0.003** | -1.09 (-2.99, 0.81) | 0.259 | 3.69 (-0.77, 8.17) | 0.105 |
P for trend | Â | 0.002** | Â | 0.295 | Â | 0.146 |